BUZZ-U.S. STOCKS ON THE MOVE-Ohr, FutureFuel, RBC Bearings
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks held near the unchanged mark on Friday, putting major indexes on track to barely snap a four-session losing streak, ahead of a speech by Federal Reserve Chair Janet Yellen that could create a volatile close on Wall Street. The Dow Jones industrial average was up 0.13 percent at 17,701.85 and the S&P 500 was up 0.17 percent at 2,059.71.
** OHR PHARMACEUTICAL INC, $2.89, -66.90 pct
The company said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, wiping out nearly two-thirds of the company's market value on Friday.
** APPLIED DNA SCIENCES INC, $2.7, -14.01 pct
The company prices its combined offering of 3.82 million shares and warrants to buy 1.53 million shares at $3 per share.
** BIOMARIN PHARMACEUTICAL INC, $129.237, +11.85 pct
Deutsche Bank raises price target on the stock to $140 from $90. Deutsche analysts said they see a potential M&A take out of about $194-$271 per share in one year, assuming the company's bone disorder drug, muscle weakness drug and blood clotting drug show positive results. Continued...